z-logo
Premium
Immunological Profiling of Haemodialysis Patients and Young Healthy Individuals with Implications for Clinical Regulatory T Cell Sorting
Author(s) -
Bergström M.,
Joly A.L.,
Seiron P.,
Isringhausen S.,
Modig E.,
Fellström B.,
Andersson J.,
Berglund D.
Publication year - 2015
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/sji.12287
Subject(s) - flow cytometry , foxp3 , immunology , medicine , transplantation , cell sorting , immune system
With the increasing interest in clinical trials with regulatory T cells (Tregs), immunological profiling of prospective target groups and standardized procedures for Treg isolation are needed. In this study, flow cytometry was used to assess peripheral blood lymphocyte profiles of young healthy individuals and patients undergoing haemodialysis treatment. Tregs obtained from the former may be used in haematopoietic stem cell transplantation and Tregs from the latter in the prevention of kidney transplant rejection. FOXP3 mRNA expression with accompanying isoform distribution was also assessed by the quantitative reverse transcriptase polymerase chain reaction. Flow‐cytometric gating strategies were systematically analysed to optimize the isolation of Tregs. Our findings showed an overall similar immunological profile of both cohorts in spite of great differences in both age and health. Analysis of flow‐cytometric gating techniques highlighted the importance of gating for both CD25high and CD127low expression in the isolation of FOXP3‐positive cells. This study provides additional insight into the immunological profile of young healthy individuals and uraemic patients as well as in‐depth analysis of flow‐cytometric gating strategies for Treg isolation, supporting the development of Treg therapy using cells from healthy donors and uraemic patients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here